LOTA S ZOTH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for LOTA S ZOTH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of LOTA S ZOTH. LOTA S ZOTH is a Chief Financial Officer in MEDIMMUNE INC /DE ($MEDI) and a Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and a Director in NEWLINK GENETICS CORP ($NLNK) and a Director in Orexigen Therapeutics, Inc. ($OREX) and a Director in HYPERION THERAPEUTICS INC ($HPTX) and a Director in Zymeworks Inc. ($ZYME) and a CHIEF SCIENTIFIC OFFICER in Spark Therapeutics, Inc. ($ONCE) and a Director in Spark Therapeutics, Inc. ($ONCE) and a Director in 89bio, Inc. ($ETNB).

Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD

Companies in which LOTA S ZOTH is an Insider

89bio, Inc.

Trading Symbol: ETNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 0 shares
Latest Transaction: Apr 19 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HYPERION THERAPEUTICS INC

Trading Symbol: HPTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 0 shares
Latest Transaction: May 08 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INOVIO PHARMACEUTICALS, INC.

Trading Symbol: GEB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of LOTA S ZOTH: Director
Holdings: 12,103 shares
Latest Transaction: May 15 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LUMOS PHARMA, INC.

Trading Symbol: NLNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 1,820 shares
Current Value: $24,879
Latest Transaction: Apr 07 2020
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MEDIMMUNE INC /DE

Trading Symbol: MEDI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of LOTA S ZOTH: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Mar 10 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Orexigen Therapeutics, Inc.

Trading Symbol: OREX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 18 2017
$OREX Market Capitalization: $70.30M
$OREX Previous Close: $4.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Spark Therapeutics, Inc.

Trading Symbol: ONCE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of LOTA S ZOTH: CHIEF SCIENTIFIC OFFICER, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Zymeworks Inc.

Trading Symbol: ZYME
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 0 shares
Latest Transaction: May 07 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of LOTA S ZOTH

Sentiment: All, ETNB, HPTX, GEB, NLNK, MEDI, OREX, ONCE, ZYME

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ZYMEZymeworks Inc.Zoth Lota S.DirectorOption ExerciseA29.499,000265,4109,000
Apr 19 2021ETNB89bio, Inc.Zoth Lota S.DirectorOption ExerciseA24.1612,500302,00012,500
Apr 19 2021ETNB89bio, Inc.Zoth Lota S.DirectorOption ExerciseA24.1612,500302,00012,500
Jun 16 2020ETNB89bio, Inc.Zoth Lota S.DirectorOption ExerciseA24.0520,000481,00020,000
May 15 2020GEBINOVIO PHARMACEUTI ...Zoth Lota S.DirectorOption ExerciseA0.008,70008,700
May 15 2020GEBINOVIO PHARMACEUTI ...Zoth Lota S.DirectorOption ExerciseA13.6513,300181,54513,300
May 12 2020ZYMEZymeworks Inc.Zoth Lota S.DirectorOption ExerciseA35.499,000319,4109,000

View all LOTA S ZOTH insider transactions.